Loading stock data…
$15.89+0.35 (+2.22%)
Avantor, Inc.
Avantor, Inc. in the Healthcare sector is trading at $15.89 with a market capitalization of $10.6B. Wall Street consensus targets $15.25 (14 analysts), implying a -4.1% move over the next 12 months. The stock is currently near its 52-week high of $16.38, remaining 45.7% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.69B↑ | $1.58B↓ | $1.66B↑ | $1.62B↓ | $1.68B |
| Gross Profit | $537.00M↑ | $500.70M↓ | $523.90M↓ | $526.50M↓ | $554.10M |
| Operating Income | $121.80M↑ | $99.50M↓ | $131.50M↓ | $136.20M↑ | $128.80M |
| Net Income | $38.10M↓ | $43.30M↓ | $52.40M↑ | -$711.80M↓ | $64.70M |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle Ea...